Sirio Pharma Company, Ltd. announced the opening of a gummy production plant at its new development and manufacturing facility in Ma’anshan, China.
Photo © iStockphoto.com/nito100
Sirio Pharma Company, Ltd. (Shantou, China), announced the opening of a gummy production plant at its new development and manufacturing facility in Ma’anshan, China. The 26,000-sq-m gummy production plant represents the completion of Phase 1 of the new facility’s multiphase construction. Once complete, the site will comprise a “Centre of Excellence” covering 240,000 sq m. The new gummy production plant is designed to expedite development and manufacturing of gummy formulations for global customers, increasing the company’s production capacity to 2.4 billion gummies per year.
“In the United States and Europe in particular, there is a significant growth potential in gummy formulations, as they are seen as a more consumer-friendly dosage form,” said Rui Yang, CSO of Sirio Pharma, in a press release. “For many of the branded firms looking to enter this market early with customized formulations, we offer clear advantages. We can expedite development and even offer taste testing options during formulation. Alternatively, we also offer ready-to-go formulations for companies that are looking to enter the market quickly because we have one of the largest ranges of existing gummy formulations of any global business. But as consumers become more discerning, we anticipate branded companies will increasingly need specialist gummy development partners and capabilities.”
Sirio has integrated research and development into the new production plant, which allows the firm to make innovative products such as liquid-filled, center-filled, swirled, and multicolored gummies. “The advantage of running an integrated site is that we can develop a much more tailored product for customers, while also expediting development timelines, thanks to a large team of in-house gummy specialists-more than 10 scientists and formulation engineers dedicated to gummies,” explained Yang. “We anticipate exponential growth for the gummy lines in 2019. And obviously, with the new capacity we have, we can supply even for the largest of nutraceutical brands” This is not Sirio’s first foray into gummies; the company opened its first gummy facility in 2007.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.